HZ89ZZZ
Medication Management Other Replacement Medication to None with None, None Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | H Substance Abuse Treatment |
| Body System | Z None |
| Operation | 8 Medication Management |
| Body Part | 9 Other Replacement Medication |
| Approach | Z None |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Monitoring and adjusting the use of replacement medications for the treatment of addiction
Procedure Overview
Medication management in substance abuse treatment refers to the ongoing clinical oversight of medications used to treat addiction, most often replacement therapies such as methadone or buprenorphine for opioid use disorder. Rather than administering a new dose, this service centers on a prescriber or care team reviewing how a patient is responding to their current regimen and making adjustments as needed. It is a recurring, supervisory activity that continues for as long as the patient remains on medication-assisted treatment.
During a medication management visit, a physician, nurse practitioner, or physician assistant evaluates the patient for signs of withdrawal, cravings, side effects, or misuse, and may increase, decrease, or otherwise modify the dose based on that assessment. This oversight is a cornerstone of medication-assisted treatment programs because replacement medications carry their own risks, including diversion and overdose, and require careful titration over time. The visits also give clinicians an opportunity to monitor for co-occurring mental health conditions and coordinate with counseling services the patient may be receiving concurrently.
Anatomy & Axis Detail
Other Replacement Medication
Other replacement medication is a residual category for pharmacologic substitution therapies used in substance abuse treatment that do not fall under the more specific named agents such as methadone, LAAM, or nicotine replacement products. It captures agents like buprenorphine formulations or emerging substitution therapies that reduce withdrawal symptoms and craving by providing a controlled, medically supervised alternative to an abused substance. Because this is a catch-all designation, accurate documentation of the specific drug and formulation in the clinical record is especially important, even though the code itself does not name the agent. Coders should confirm that no more specific replacement medication code applies before defaulting to this category, since payer and registry reporting often depend on capturing the precise substance being used for replacement therapy.
Coding & Documentation
This code applies when the documentation shows a clinician reviewing and adjusting an existing medication regimen for addiction treatment, such as changing a buprenorphine dose after evaluating the patient's response. The note should reflect clinical decision-making about the medication itself, not simply that a dose was administered. A frequent coding error is applying this instead of Pharmacotherapy when the encounter actually involved starting or continuing a medication without any monitoring or dose adjustment documented, or applying it when the visit was purely a counseling session that happened to mention medication in passing.
Commonly Confused With
The closest point of confusion is with Pharmacotherapy, also in this section. Pharmacotherapy captures the act of administering the replacement medication itself, while Medication Management captures the evaluation and adjustment of that regimen over time; a single encounter can sometimes involve both, but each needs its own supporting documentation. It can also be confused with routine medication administration coded elsewhere in ICD-10-PCS when the substance being given is not part of an addiction treatment protocol.